Data on the regulator’s website show Zydus Lifesciences and Alkem Laboratories received approval last week to manufacture and sell generic semaglutide for weight-loss and diabetes treatment
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






